-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Akari Therapeutics Plc quarterly/annual General and Administrative Expense history and growth rate from Q1 2014 to Q2 2024.
- Akari Therapeutics Plc General and Administrative Expense for the quarter ending June 30, 2024 was $1.28M, a 44.2% decline year-over-year.
- Akari Therapeutics Plc annual General and Administrative Expense for 2023 was $8.29M, a 2.8% decline from 2022.
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)